Evgeniy V. Suslov

Severnij Pr. 1
Chernogolovka, MOS 142432, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Hydroxamic Acids Containing a Bicyclic Pinane Backbone as Epigenetic and Metabolic Regulators: Synergizing Agents to Overcome Cisplatin Resistance.

Hydroxamic Acids Containing a Bicyclic Pinane Backbone as Epigenetic and Metabolic Regulators: Synergizing Agents to Overcome Cisplatin Resistance.

Journal: Cancers

Published: August 30, 2023

Structure-Based Design, Synthesis, and Biological Evaluation of the Cage-Amide Derived Orthopox Virus Replication Inhibitors.

Structure-Based Design, Synthesis, and Biological Evaluation of the Cage-Amide Derived Orthopox Virus Replication Inhibitors.

Journal: Viruses

Published: December 02, 2022

New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.

New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.

Journal: Molecules (Basel, Switzerland)

Published: July 28, 2022

Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.

Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.

Journal: Molecules (Basel, Switzerland)

Published: April 29, 2022

Novel Bispidine-Monoterpene Conjugates-Synthesis and Application as Ligands for the Catalytic Ethylation of Chalcones.

Novel Bispidine-Monoterpene Conjugates-Synthesis and Application as Ligands for the Catalytic Ethylation of Chalcones.

Journal: Molecules (Basel, Switzerland)

Published: November 27, 2021

Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments.

Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments.

Journal: Molecules (Basel, Switzerland)

Published: April 21, 2021

Azaadamantanes, a New Promising Scaffold for Medical Chemistry.

Azaadamantanes, a New Promising Scaffold for Medical Chemistry.

Journal: Russian journal of bioorganic chemistry

Published: February 25, 2021

Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.

Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.

Journal: Anti-cancer agents in medicinal chemistry

Published: June 26, 2018

Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.

Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.

Journal: Bioorganic chemistry

Published: June 28, 2017

Anti-influenza activity of diazaadamantanes combined with monoterpene moieties.

Anti-influenza activity of diazaadamantanes combined with monoterpene moieties.

Journal: Bioorganic & medicinal chemistry letters

Published: June 14, 2017

Synthesis and Analgesic Activity of Amines Combining Diazaadamantane and Monoterpene Fragments.

Synthesis and Analgesic Activity of Amines Combining Diazaadamantane and Monoterpene Fragments.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))

Published: November 09, 2016

Inhibitory Properties of Nitrogen-Containing Adamantane Derivatives with Monoterpenoid Fragments Against Tyrosyl-DNA Phosphodiesterase I

Inhibitory Properties of Nitrogen-Containing Adamantane Derivatives with Monoterpenoid Fragments Against Tyrosyl-DNA Phosphodiesterase I

Journal: Bioorganicheskaia khimiia

Published: April 30, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026